Clinical Trial Update: Radiofrequency Ablation for Biliopancreatic Malignancy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of radiofrequency ablation for biliopancreatic malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Obstructive Jaundice
• Pancreatic Cancer

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Pancreas Cancer, Cholangiocarcinoma | Phase 2 | Status: COMPLETED